Form 4/A for APUS Apimeds Pharmaceuticals US, Inc.
Accepted 2025-06-11 00:00:00 ET · period of report 2025-05-12 · accession 0001474506-25-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2025-06-11 | 2025-05-12 | APUS | Inscobee Inc. | 10% | C - Cnv Deriv | $2.60 | +115.1K | 2.06M | +6% | +$299.3K |
| DMA | 2025-06-11 | 2025-05-12 | APUS | Inscobee Inc. | 10% | C - Cnv Deriv | — | 0 | 0 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2025-05-12 | C | A | 44,041 | $2.60 | 2,099,747 | D | — | — | |
| 2 | Common | Common Stock, par value $0.01 per share | 2025-05-12 | C | A | 71,090 | $2.60 | 2,055,706 | D | — | — | |
| 3 | Derivative | Convertible Promissory Note | 2025-05-12 | C | A | — | $0.00 | 0 | D | $2.60 · — to — | 71,090 Common Stock, par value $0.01 per share | (F1) On March 21, 2022, Apimeds Pharmaceuticals US, Inc. (the "Issuer") issued to Inscobee Inc. ("Inscobee") a convertible promissory note in the principal amount of $160,000 (as amended, the "March 2022 Note"). All outstanding principal and accrued and unpaid interest owed under the March 2022 Note is due and payable on the earlier of (i) December 31, 2026, or (ii) the consummation of an offering of the Issuer's common stock resulting in the listing of the Issuer's common stock on the NYSE American, or other national securities exchange (a "Qualified Offering"). The March 2022 Note bears interest at an annual rate of 5%. The March 2022 Note is convertible into shares of common stock at a conversion price of $2.60 per share (the "Conversion Price"). The amount reported in Column 3 of Table II represents the original principal amount of $160,000, plus $24,833 of accrued and unpaid interest. |
| 4 | Derivative | Convertible Promissory Note | 2025-05-12 | C | A | — | $0.00 | 0 | D | $2.60 · — to — | 44,041 Common Stock, par value $0.01 per share | (F3) On June 3, 2022, the Issuer issued to Inscobee a convertible promissory note in the principal amount of $100,000 (as amended, the "June 2022 Note"). All outstanding principal and accrued and unpaid interest owed under the June 2022 Note is due and payable on the earlier of (i) December 31, 2026, or (ii) the consummation of a Qualified Offering. The June 2022 Note bears interest at an annual rate of 5%. The June 2022 Note is convertible into shares of common stock at the Conversion Price. The amount reported in Column 3 of Table II represents the original principal amount of $100,000, plus $14,507 of accrued and unpaid interest. |